Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Wein Matthew sold 558 Metagenomi Therapeutics, Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 10, 2026
On Jun 5, 2026, Wein Matthew (See Remarks) sold 558 Metagenomi Therapeutics, Inc. shares at US$1.30 for US$725, leaving 126,491 shares. Filed Jun 10, 2026 (Form 4).
- Sold
- 558 shares
- Price
- US$1.30
- Value
- US$725
- Holding after
- 126,491 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Sale | 558 | US$1.30 | 126,491 | Direct |
Source
Related
- Metagenomi Therapeutics, Inc.
- Wein Matthew
- Metagenomi Therapeutics, Inc. shareholders
- Form 4 · Wein Matthew · Sep 10, 2026
- Form 4 · Wein Matthew · Apr 3, 2026
- Form 4 · Reid Laurence · Sep 11, 2026
- Form 4 · Irish Jian · Sep 10, 2026
- Form 4 · Wapnick Pamela · Sep 10, 2026
- Schedule 13G · Thomas Brian C. · Sep 10, 2026
- Form 4 · Wapnick Pamela · Jun 10, 2026